Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0001339
Disease: Acute pancreatitis
Acute pancreatitis
0.010 Biomarker disease BEFREE Patients were classified into the following groups based on a review of medical records: (1) acute recurrent idiopathic pancreatitis (ARIP) with or without underlying chronic pancreatitis; (2) idiopathic chronic pancreatitis (ICP) without a history of ARP; (3) an unexplained first episode of acute pancreatitis (AP)<35 years of age; and (4) family history of pancreatitis. 28440306 2017
CUI: C0220630
Disease: Adult Liver Carcinoma
Adult Liver Carcinoma
0.010 Biomarker disease BEFREE MANF inhibits liver cancer via SUMOylation-related suppression of NF-κB/Snail signaling pathway and epithelial-mesenchymal transition. 31469428 2019
CUI: C0002395
Disease: Alzheimer's Disease
Alzheimer's Disease
0.010 Biomarker disease BEFREE However, whether MANF exerts its protective effect against Aβ neurotoxicity in AD remains unknown. 30760285 2019
CUI: C0004238
Disease: Atrial Fibrillation
Atrial Fibrillation
0.010 Biomarker disease BEFREE The serum MANF in patients with AF was markedly lower than that in patients with SR, which was inversely correlated with atrial apoptosis in patients with AF. 31789884 2020
CUI: C0004364
Disease: Autoimmune Diseases
Autoimmune Diseases
0.020 Biomarker group BEFREE Of them 12 are associated with other autoimmune diseases than SLE, whereas three genes (ZNF804A, CDK1, and MANF) have not previously been associated with autoimmunity. 28740209 2017
CUI: C0004364
Disease: Autoimmune Diseases
Autoimmune Diseases
0.020 AlteredExpression group BEFREE Here, we determined that ER stress inducible protein Mesencephalic Astrocyte-derived Neurotrophic Factor (MANF) was up-regulated in autoimmune diseases and inflammatory disease models. 25640174 2015
CUI: C0079731
Disease: B-Cell Lymphomas
B-Cell Lymphomas
0.010 AlteredExpression group BEFREE MANF was mainly expressed in rat neurons, and its expression increased significantly at 3 h after SAH induction and peaked at 24 h. Stereotactic injection of rh-MANF into the cerebroventricle significantly increased the level of MANF, p-Akt, p-mouse double minute 2 homolog (p-MDM2), and B-cell lymphoma 2 (Bcl-2) in brain tissue, whereas it down-regulated the expression of P53, Bcl-2-associated X protein (Bax), and cleaved caspase-3, which indicated that neuronal apoptosis was remarkably suppressed. 30211660 2019
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.010 Biomarker disease BEFREE We constructed a set of lentiviral vectors that contain or lack the highly conserved final four amino acids of MANF ("RTDL"), which resemble the canonical ER retention signal ("KDEL"), to study MANF regulation in neuroblastoma cells and rat primary cortical neurons. 23255601 2013
CUI: C0007785
Disease: Cerebral Infarction
Cerebral Infarction
0.030 Biomarker disease BEFREE Many groups, including ours, have proved that MANF rescues neuronal loss in several neurological disorders, such as Parkinson's disease and cerebral ischemia. 30760285 2019
CUI: C0007785
Disease: Cerebral Infarction
Cerebral Infarction
0.030 Biomarker disease BEFREE The more interesting results in this study were that MANF repressed the cleavage of caspase-3 triggered by focal cerebral ischemia. 25001514 2014
CUI: C0007785
Disease: Cerebral Infarction
Cerebral Infarction
0.030 Biomarker disease BEFREE Effects of mesencephalic astrocyte-derived neurotrophic factor on cerebral angiogenesis in a rat model of cerebral ischemia. 31785307 2020
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.040 Biomarker group BEFREE In this study, we examined the protective effect of adeno-associated virus serotype 7 encoding MANF in a rodent model of stroke. 20685313 2010
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.040 Biomarker group BEFREE The beneficial effect of MANF treatment on the reversal of stroke-induced behavioral deficits implies that MANF-based therapies could be used for the repair of brain tissue after stroke. 29806020 2018
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.040 Biomarker group BEFREE Recombinant human MANF was administered intracerebroventricularly 24 h after stroke. 31785307 2020
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.040 Biomarker group BEFREE MANF Promotes Differentiation and Migration of Neural Progenitor Cells with Potential Neural Regenerative Effects in Stroke. 29050872 2018
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.010 Biomarker disease BEFREE We constructed a set of lentiviral vectors that contain or lack the highly conserved final four amino acids of MANF ("RTDL"), which resemble the canonical ER retention signal ("KDEL"), to study MANF regulation in neuroblastoma cells and rat primary cortical neurons. 23255601 2013
CUI: C0694539
Disease: Chronic atrial fibrillation
Chronic atrial fibrillation
0.010 AlteredExpression disease BEFREE These findings suggest that MANF down-regulation may lead to more atrial apoptosis in human chronic AF, indicating MANF as a potential therapeutic agent in AF treatment. 31789884 2020
CUI: C0018802
Disease: Congestive heart failure
Congestive heart failure
0.010 Biomarker disease BEFREE Functions for the cardiomyokine, MANF, in cardioprotection, hypertrophy and heart failure. 20970425 2011
CUI: C0344315
Disease: Depressed mood
Depressed mood
0.010 Biomarker phenotype BEFREE Circulating MANF concentrations were significantly higher in PD patients compared to controls (<i>P</i> < 0.001) and were positively correlated with Beck Depression Inventory (BDI) depression rating. 31555085 2019
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.010 Biomarker disease BEFREE Circulating MANF concentrations were significantly higher in PD patients compared to controls (<i>P</i> < 0.001) and were positively correlated with Beck Depression Inventory (BDI) depression rating. 31555085 2019
CUI: C0011847
Disease: Diabetes
Diabetes
0.030 Biomarker disease BEFREE Here we will discuss the structural motifs and physiological functions of CDNF and MANF as well as their therapeutic potential for the treatment of neurodegenerative diseases and diabetes. 27425895 2017
CUI: C0011847
Disease: Diabetes
Diabetes
0.030 AlteredExpression disease BEFREE Furthermore, increased MANF levels has been detected in the sera of young children with newly diagnosed Type 1 (T1D) diabetes and Type 2 (T2D) diabetic patients. 30386256 2018
CUI: C0011847
Disease: Diabetes
Diabetes
0.030 Biomarker disease BEFREE Recent studies in rodent models have demonstrated that MANF mitigates diabetes, exerts neurotrophic function in neurodegenerative disease, protects cardiomyocytes and neurons in myocardial infarction and cerebral ischemia, respectively, and promotes immune cell phenotype switch from proinflammatory macrophages to prorepair anti-inflammatory macrophages. 28719799 2017
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.030 Biomarker group BEFREE Here we will discuss the structural motifs and physiological functions of CDNF and MANF as well as their therapeutic potential for the treatment of neurodegenerative diseases and diabetes. 27425895 2017
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.030 Biomarker group BEFREE Recent studies in rodent models have demonstrated that MANF mitigates diabetes, exerts neurotrophic function in neurodegenerative disease, protects cardiomyocytes and neurons in myocardial infarction and cerebral ischemia, respectively, and promotes immune cell phenotype switch from proinflammatory macrophages to prorepair anti-inflammatory macrophages. 28719799 2017